Catalyst
Slingshot members are tracking this event:
PDUFA of Enbrel in Pediatric patients with moderate-severe psoriasis set for Nov 5 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AMGN | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 04, 2016
Occurred Source:
http://www.amgen.com/media/news-releases/2016/11/fda-approves-expanded-use-of-enbrel-etanercept-to-treat-children-with-chronic-moderatetosevere-plaque-psoriasis/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Enbrel, Pediatric Patients, Psoriasis
